trial

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

NCTId NCT00661869
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 295 (actual)
Sponsored by Manhattan Psychiatric Center
Primary completion 2007-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
295 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2006-09
Primary completion
2007-09
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Wellness Program

Sponsors

Manhattan Psychiatric CenterLead Sponsor
Eli Lilly and CompanyCollaborator

Investigators

1
Jean-Pierre Lindenmayer, M.D.Principal Investigator

Sites

1 total
New York, United States

Facts & assertions

4 sourced
Enrollment
295
Phase
NA
Primary Completion Date
2007-09
Status
COMPLETED
relationships
The graph out of here
drug
Wellness Program
drug
lead_sponsor
Manhattan Psychiatric Center
company
collaborator
Eli Lilly and Company
company
indication
Bipolar Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Jean-Pierre Lindenmayer, M.D.
person